Cargando…
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug carrier, and the only NP system currently approved by the FDA for clinical use, owing to their advantageous physicochemical properties and excellent biocompatibility. Recent advances in liposome technology have been...
Autores principales: | Almeida, Bethany, Nag, Okhil K., Rogers, Katherine E., Delehanty, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730700/ https://www.ncbi.nlm.nih.gov/pubmed/33271886 http://dx.doi.org/10.3390/molecules25235672 |
Ejemplares similares
-
Special Issue “Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions”
por: Nag, Okhil K., et al.
Publicado: (2023) -
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
por: Nag, Okhil K., et al.
Publicado: (2019) -
Liquid Crystal Nanoparticle Conjugates for Scavenging Reactive Oxygen Species in Live Cells
por: Nag, Okhil K., et al.
Publicado: (2022) -
Surface Engineering of Liposomes for Stealth Behavior
por: Nag, Okhil K., et al.
Publicado: (2013) -
Recent Applications of Liposomes in Ophthalmic Drug Delivery
por: Mishra, Gyan P., et al.
Publicado: (2011)